Fennec Pharmaceuticals (FENC) Total Debt (QoQ) (2011 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 400.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2017 | 44,672.12% |
| Sep 30, 2017 | 96.32% |
| Jun 30, 2017 | 167.61% |
| Mar 31, 2017 | 115.15% |
| Dec 31, 2016 | -10.81% |
| Sep 30, 2016 | -33.93% |
| Jun 30, 2016 | 43.59% |
| Mar 31, 2016 | -52.44% |
| Dec 31, 2015 | -11.83% |
| Sep 30, 2015 | -69.90% |
| Jun 30, 2015 | -55.48% |
| Mar 31, 2015 | -47.38% |
| Dec 31, 2014 | -62.30% |
| Sep 30, 2014 | -34.43% |
| Jun 30, 2014 | -3.30% |
| Mar 31, 2014 | 92.73% |
| Dec 31, 2013 | -34.74% |
| Sep 30, 2013 | 63.82% |
| Jun 30, 2013 | -73.78% |
| Mar 31, 2013 | 53.81% |
| Dec 31, 2012 | 433.76% |
| Sep 30, 2012 | 12.48% |
| Jun 30, 2012 | -36.80% |
| Mar 31, 2012 | -65.53% |
| Dec 31, 2011 | -46.36% |
| Sep 30, 2011 | 30.66% |